share_log

康辰药业关于中药创新药ZY5301临床研究结果荣登《JAMA》子刊的公告

Announcement from Beijing Konruns Pharmaceutical on traditional Chinese medicine innovative drug ZY5301 clinical research results being featured in the sub-journal of JAMA.

SZSI ·  Jul 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more